Citrus flavanones: What is their role in cardiovascular protection?

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 36, 2012, Pages 8809-8822

  Chanet, Audrey ^a,b   Milenkovic, Dragan ^a,b   Manach, Claudine ^a,b   Mazur, Andrzej ^a,b   Morand, Christine ^a,b  

^a CRNH AUVERGNE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

cardiovascular protection; citrus flavanones; inflammation; insulin resistance; lipid profile; oxidative stress; vascular function

Indexed keywords

CARDIOVASCULAR PROTECTION; CITRUS FLAVANONES; INFLAMMATION; INSULIN RESISTANCE; LIPID PROFILE; VASCULAR FUNCTIONS;

INSULIN; OXIDATIVE STRESS;

DISEASES;

FLAVANONE; FLAVANONE DERIVATIVE; PLANT EXTRACT;

ANIMAL; CARDIOVASCULAR DISEASE; CHEMISTRY; CITRUS; CONFERENCE PAPER; HUMAN;

ANIMALS; CARDIOVASCULAR DISEASES; CITRUS; FLAVANONES; HUMANS; PLANT EXTRACTS;

ANIMALIA; CITRUS;

EID: 84864354757     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf300669s     Document Type: Conference Paper

References (109)

1. Dauchet, L.; Amouyel, P.; Dallongeville, J. Fruit and vegetable consumption and risk of stroke - a meta-analysis of cohort studies Neurology 2005, 65, 1193-1197
2. Dauchet, L.; Amouyel, P.; Hercberg, S.; Dallongeville, J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies J. Nutr. 2006, 136, 2588-2593
3. He, F. J.; Nowson, C. A.; MacGregor, G. A. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies Lancet 2006, 367, 320-326
4. He, F. J.; Nowson, C. A.; Lucas, M.; MacGregor, G. A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies J. Hum. Hypertens. 2007, 21, 717-728
5. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability Am. J. Clin. Nutr. 2004, 79, 727-747
6. Ovaskainen, M. L.; Torronen, R.; Koponen, J. M.; Sinkko, H.; Hellstrom, J.; Reinivuo, H.; Mattila, P. Dietary intake and major food sources of polyphenols in Finnish adults J. Nutr. 2008, 138, 562-566
7. Perez-Jimenez, J.; Fezeu, L.; Touvier, M.; Arnault, N.; Manach, C.; Hercberg, S.; Galan, P.; Scalbert, A. Dietary intake of 337 polyphenols in French adults Am. J. Clin. Nutr. 2011, 93, 1220-1228
8. Arts, I. C. W.; Hollman, P. C. H. Polyphenols and disease risk in epidemiologic studies Am. J. Clin. Nutr. 2005, 81, 317s-325s
9. Hollman, P. C.; Geelen, A.; Kromhout, D. Dietary flavonol intake may lower stroke risk in men and women J. Nutr. 2010, 140, 600-604
10. Edwards, R. L.; Lyon, T.; Litwin, S. E.; Rabovsky, A.; Symons, J. D.; Jalili, T. Quercetin reduces blood pressure in hypertensive subjects J. Nutr. 2007, 137, 2405-2411
11. Egert, S.; Boesch-Saadatmandi, C.; Wolffram, S.; Rimbach, G.; Muller, M. J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype J. Nutr. 2010, 140, 278-284
12. Erlund, I.; Koli, R.; Alfthan, G.; Marniemi, J.; Puukka, P.; Mustonen, P.; Mattila, P.; Jula, A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol Am. J. Clin. Nutr. 2008, 87, 323-331
13. Hooper, L.; Kroon, P. A.; Rimm, E. B.; Cohn, J. S.; Harvey, I.; Le Cornu, K. A.; Ryder, J. J.; Hall, W. L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials Am. J. Clin. Nutr. 2008, 88, 38-50
14. Loke, W. M.; Hodgson, J. M.; Proudfoot, J. M.; McKinley, A. J.; Puddey, I. B.; Croft, K. D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men Am. J. Clin. Nutr. 2008, 88, 1018-1025
15. Loke, W. M.; Proudfoot, J. M.; Hodgson, J. M.; McKinley, A. J.; Hime, N.; Magat, M.; Stocker, R.; Croft, K. D. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction Arterioscler. Thromb. Vasc. Biol. 2010, 30, 749-757
16. Mulvihill, E. E.; Assini, J. M.; Sutherland, B. G.; DiMattia, A. S.; Khami, M.; Koppes, J. B.; Sawyez, C. G.; Whitman, S. C.; Huff, M. W. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice Arterioscle., Thromb. Vasc. Biol. 2010, 30, 742-748
17. Nardini, M.; Natella, F.; Scaccini, C. Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies Platelets 2007, 18, 224-243
18. Schroeter, H.; Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C. L.; Hollenberg, N. K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H. H.; Kelm, M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 1024-1029
19. Widlansky, M. E.; Hamburg, N. M.; Anter, E.; Holbrook, M.; Kahn, D. F.; Elliott, J. G.; Keaney, J. F., Jr.; Vita, J. A. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease J. Am. Coll. Nutr. 2007, 26, 95-102
20. Peterson, J. J.; Beecher, G. R.; Bhagwat, S. A.; Dwyer, J. T.; Gebhardt, S. E.; Haytowitz, D. B.; Holden, J. M. Flavanones in grapefruit, lemons, and limes: a compilation and review of the data from the analytical literature J. Food Compos. Anal. 2006, 19, S74-S80
21. Peterson, J. J.; Dwyer, J. T.; Beecher, G. R.; Bhagwat, S. A.; Gebhardt, S. E.; Haytowitz, D. B.; Holden, J. M. Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: a compilation and review of the data from the analytical literature J. Food Compos. Anal. 2006, 19, S66-S73
22. Berhow, M. A. Flavonoid accumulation in tissue and cell culture. Studies in Citrus and other plant species Adv. Exp. Med. Biol. 1998, 439, 67-84
23. Tomas-Barberan, F. A.; Clifford, M. N. Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden J. Sci. Food Agric. 2000, 80, 1073-1080
24. Nogata, Y.; Sakamoto, K.; Shiratsuchi, H.; Ishii, T.; Yano, M.; Ohta, H. Flavonoid composition of fruit tissues of citrus species Biosci., Biotechnol., Biochem. 2006, 70, 178-192
25. Neveu, V.; Perez-Jimenez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.; Wishart, D.; Scalbert, A. Phenol-Explorer: an Online Comprehensive Database on Polyphenol Contents in Foods, 2010; bap024.
26. Ross, S. A.; Ziska, D. S.; Zhao, K.; ElSohly, M. A. Variance of common flavonoids by brand of grapefruit juice Fitoterapia 2000, 71, 154-161
27. Erdman, J. W., Jr.; Balentine, D.; Arab, L.; Beecher, G.; Dwyer, J. T.; Folts, J.; Harnly, J.; Hollman, P.; Keen, C. L.; Mazza, G.; Messina, M.; Scalbert, A.; Vita, J.; Williamson, G.; Burrowes, J. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr. 2007, 137, 718S-737S
28. Lagiou, P.; Samoli, E.; Lagiou, A.; Tzonou, A.; Kalandidi, A.; Peterson, J.; Dwyer, J.; Trichopoulos, D. Intake of specific flavonoid classes and coronary heart disease - a case-control study in Greece Eur. J. Clin. Nutr. 2004, 58, 1643-1648
29. Rossi, M.; Garavello, W.; Talamini, R.; La Vecchia, C.; Franceschi, S.; Lagiou, P.; Zambon, P.; Dal Maso, L.; Bosetti, C.; Negri, E. Flavonoids and risk of squamous cell esophageal cancer Int. J. Cancer 2007, 120, 1560-1564
30. Rossi, M.; Garavello, W.; Talamini, R.; Negri, E.; Bosetti, C.; Dal Maso, L.; Lagiou, P.; Tavani, A.; Polesel, J.; Barzan, L.; Ramazzotti, V.; Franceschi, S.; La Vecchia, C. Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1621-1625
31. Tavani, A.; Spertini, L.; Bosetti, C.; Parpinel, M.; Gnagnarella, P.; Bravi, F.; Peterson, J.; Dwyer, J.; Lagiou, P.; Negri, E.; La Vecchia, C. Intake of specific flavonoids and risk of acute myocardial infarction in Italy Public Health Nutr. 2006, 9, 369-374
32. Zamora-Ros, R.; Andres-Lacueva, C.; Lamuela-Raventos, R. M.; Berenguer, T.; Jakszyn, P.; Barricarte, A.; Ardanaz, E.; Amiano, P.; Dorronsoro, M.; Larranaga, N.; Martinez, C.; Sanchez, M. J.; Navarro, C.; Chirlaque, M. D.; Tormo, M. J.; Quiros, J. R.; Gonzalez, C. A. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain) J. Am. Diet. Assoc. 2010, 110, 390-398
33. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols J. Nutr. 2000, 130, 2073S-2085S
34. Urpi-Sarda, M.; Rothwell, J.; Morand, C.; Manach, C. Bioavailability of flavanones. In Flavonoids and Related Compounds: Bioavailability and Function; Spencer, J.; Crozier, A., Eds.; CRC Press: Boca Raton, FL, 2012; pp 1-65.
35. Ishii, K.; Furuta, T.; Kasuya, Y. Mass spectrometric identification and high-performance liquid chromatographic determination of a flavonoid glycoside naringin in human urine J. Agric. Food Chem. 2000, 48, 56-59
36. Brett, G. M.; Hollands, W.; Needs, P. W.; Teucher, B.; Dainty, J. R.; Davis, B. D.; Brodbelt, J. S.; Kroon, P. A. Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion Br. J. Nutr. 2009, 101, 664-675
37. Vallejo, F.; Larrosa, M.; Escudero, E.; Zafrilla, M. P.; Cerda, B.; Boza, J.; Garcia-Conesa, M. T.; Espín, J. C.; Tomas-Barberan, F. A. Concentration and solubility of flavanones in orange beverages affect their bioavailability in humans J. Agric. Food Chem. 2010, 58, 6516-6524
38. Bredsdorff, L.; Nielsen, I. L.; Rasmussen, S. E.; Cornett, C.; Barron, D.; Bouisset, F.; Offord, E.; Williamson, G. Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from α- rhamnosidase-treated orange juice in human subjects Br. J. Nutr. 2010, 103, 1602-1609
39. Erlund, I.; Silaste, M. L.; Alfthan, G.; Rantala, M.; Kesaniemi, Y. A.; Aro, A. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables Eur. J. Clin. Nutr. 2002, 56, 891-898
40. Gardana, C.; Guarnieri, S.; Riso, P.; Simonetti, P.; Porrini, M. Flavanone plasma pharmacokinetics from blood orange juice in human subjects Br. J. Nutr. 2007, 98, 165-172
41. Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; Remesy, C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice Eur. J. Clin. Nutr. 2003, 57, 235-242
42. Mullen, W.; Archeveque, M. A.; Edwards, C. A.; Matsumoto, H.; Crozier, A. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt J. Agric. Food Chem. 2008, 56, 11157-11164
43. Nielsen, I. L.; Chee, W. S.; Poulsen, L.; Offord-Cavin, E.; Rasmussen, S. E.; Frederiksen, H.; Enslen, M.; Barron, D.; Horcajada, M. N.; Williamson, G. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial J. Nutr. 2006, 136, 404-408
44. Erlund, I.; Meririnne, E.; Alfthan, G.; Aro, A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice J. Nutr. 2001, 131, 235-241
45. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 2005, 81, 230S-242S
46. Lee, Y. S.; Reidenberg, M. M. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man Pharmacology 1998, 56, 314-317
47. Dauchet, L.; Ferrieres, J.; Arveiler, D.; Yarnell, J. W.; Gey, F.; Ducimetiere, P.; Ruidavets, J. B.; Haas, B.; Evans, A.; Bingham, A.; Amouyel, P.; Dallongeville, J. Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study Br. J. Nutr. 2004, 92, 963-972
48. Joshipura, K. J.; Hu, F. B.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Colditz, G.; Ascherio, A.; Rosner, B.; Spiegelman, D.; Willett, W. C. The effect of fruit and vegetable intake on risk for coronary heart disease Ann. Intern. Med. 2001, 134, 1106-1114
49. Joshipura, K. J.; Ascherio, A.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Hennekens, C. H.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake in relation to risk of ischemic stroke JAMA, J. Am. Med Assoc. 1999, 282, 1233-1239
50. Mizrahi, A.; Knekt, P.; Montonen, J.; Laaksonen, M. A.; Heliovaara, M.; Jarvinen, R. Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption Br. J. Nutr. 2009, 102, 1075-1083
51. Yamada, T.; Hayasaka, S.; Shibata, Y.; Ojima, T.; Saegusa, T.; Gotoh, T.; Ishikawa, S.; Nakamura, Y.; Kayaba, K. Grp, J. M. S. C. S.: Frequency of citrus fruit intake is associated with the incidence of cardiovascular disease: The Jichi Medical School Cohort Study J. Epidemiol. 2011, 21, 169-175
52. Mink, P. J.; Scrafford, C. G.; Barraj, L. M.; Harnack, L.; Hong, C. P.; Nettleton, J. A.; Jacobs, D. R., Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women Am. J. Clin. Nutr. 2007, 85, 895-909
53. Cassidy, A.; Rimm, E. B.; O'Reilly, E. J.; Logroscino, G.; Kay, C.; Chiuve, S. E.; Rexrode, K. M. Dietary flavonoids and risk of stroke in women Stroke, J. Cerebral Circ. 2012, 43, 946-951
54. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; Rissanen, H.; Heliovaara, M.; Reunanen, A.; Hakulinen, T.; Aromaa, A. Flavonoid intake and risk of chronic diseases Am. J. Clin. Nutr. 2002, 76, 560-568
55. Widlansky, M. E.; Gokce, N.; Keaney, J. F., Jr.; Vita, J. A. The clinical implications of endothelial dysfunction J. Am. Coll. Cardiol. 2003, 42, 1149-1160
56. Reshef, N.; Hayari, Y.; Goren, C.; Boaz, M.; Madar, Z.; Knobler, H. Antihypertensive effect of sweetie fruit in patients with stage I hypertension Am. J. Hypertens. 2005, 18, 1360-1363
57. Morand, C.; Dubray, C.; Milenkovic, D.; Lioger, D.; Martin, J. F.; Scalbert, A.; Mazur, A. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers Am. J. Clin. Nutr. 2011, 93, 73-80
58. Rizza, S.; Muniyappa, R.; Iantorno, M.; Kim, J. A.; Chen, H.; Pullikotil, P.; Senese, N.; Tesauro, M.; Lauro, D.; Cardillo, C.; Quon, M. J. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome J. Clin. Endocrinol. Metab. 2011, 96, E782-E792
59. Jung, U. J.; Kim, H. J.; Lee, J. S.; Lee, M. K.; Kim, H. O.; Park, E. J.; Kim, H. K.; Jeong, T. S.; Choi, M. S. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects Clin. Nutr. 2003, 22, 561-568
60. Demonty, I.; Lin, Y.; Zebregs, Y. E.; Vermeer, M. A.; van der Knaap, H. C.; Jakel, M.; Trautwein, E. A. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women J. Nutr. 2010, 140, 1615-1620
61. Stocker, R.; Keaney, J. F., Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 2004, 84, 1381-1478
62. Ross, R. Atherosclerosis is an inflammatory disease Am. Heart J. 1999, 138, S419-S420
63. Milenkovic, D.; Deval, C.; Dubray, C.; Mazur, A.; Morand, C. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study PLoS One 2011, 6, e26669
64. Cesar, T. B.; Aptekmann, N. P.; Araujo, M. P.; Vinagre, C. C.; Maranhao, R. C. Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects Nutr. Res. (N.Y.) 2010, 30, 689-694
65. Gorinstein, S.; Caspi, A.; Libman, I.; Katrich, E.; Lerner, H. T.; Trakhtenberg, S. Preventive effects of diets supplemented with sweetie fruits in hypercholesterolemic patients suffering from coronary artery disease Prev. Med. 2004, 38, 841-847
66. Gorinstein, S.; Caspi, A.; Libman, I.; Katrich, E.; Lerner, H. T.; Trakhtenberg, S. Fresh Israeli jaffa sweetie juice consumption improves lipid metabolism and increases antioxidant capacity in hypercholesterolemic patients suffering from coronary artery disease: studies in vitro and in humans and positive changes in albumin and fibrinogen fractions J. Agric. Food Chem. 2004, 52, 5215-5222
67. Gorinstein, S.; Caspi, A.; Libman, I.; Lerner, H. T.; Huang, D.; Leontowicz, H.; Leontowicz, M.; Tashma, Z.; Katrich, E.; Feng, S.; Trakhtenberg, S. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans J. Agric. Food Chem. 2006, 54, 1887-1892
68. Kurowska, E. M.; Spence, J. D.; Jordan, J.; Wetmore, S.; Freeman, D. J.; Piche, L. A.; Serratore, P. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia Am. J. Clin. Nutr. 2000, 72, 1095-1100
69. Johnston, C. S.; Dancho, C. L.; Strong, G. M. Orange juice ingestion and supplemental vitamin C are equally effective at reducing plasma lipid peroxidation in healthy adult women J. Am. Coll. Nutr. 2003, 22, 519-523
70. Ghanim, H.; Sia, C. L.; Upadhyay, M.; Korzeniewski, K.; Viswanathan, P.; Abuaysheh, S.; Mohanty, P.; Dandona, P. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression Am. J. Clin. Nutr. 2010, 91, 940-949
71. Sanchez-Moreno, C.; Cano, M. P.; de Ancos, B.; Plaza, L.; Olmedilla, B.; Granado, F.; Martin, A. Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans Am. J. Clin. Nutr. 2003, 78, 454-460
72. Choe, S. C.; Kim, H. S.; Jeong, T. S.; Bok, S. H.; Park, Y. B. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits J. Cardiovasc. Pharmacol. 2001, 38, 947-955
73. Lee, C. H.; Jeong, T. S.; Choi, Y. K.; Hyun, B. H.; Oh, G. T.; Kim, E. H.; Kim, J. R.; Han, J. I.; Bok, S. H. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits Biochem. Biophys. Res. Commun. 2001, 284, 681-688
74. Chanet, A.; Milenkovic, D.; Deval, C.; Potier, M.; Constans, J.; Mazur, A.; Bennetau-Pelissero, C.; Morand, C.; Berard, A. M. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice J. Nutr. Biochem. 2012, 23, 469-477
75. Yamamoto, M.; Suzuki, A.; Hase, T. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54, 95-98
76. Yamada, M.; Tanabe, F.; Arai, N.; Mitsuzumi, H.; Miwa, Y.; Kubota, M.; Chaen, H.; Kibata, M. Bioavailability of glucosyl hesperidin in rats Biosci., Biotechnol., Biochem. 2006, 70, 1386-1394
77. Yamamoto, M.; Suzuki, A.; Jokura, H.; Yamamoto, N.; Hase, T. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats Nutrition 2008, 24, 470-476
78. Liu, L.; Xu, D. M.; Cheng, Y. Y. Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells J. Agric. Food Chem. 2008, 56, 824-829
79. Appeldoorn, M. M.; Venema, D. P.; Peters, T. H.; Koenen, M. E.; Arts, I. C.; Vincken, J. P.; Gruppen, H.; Keijer, J.; Hollman, P. C. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro J. Agric. Food Chem. 2009, 57, 7693-7699
80. Bok, S. H.; Lee, S. H.; Park, Y. B.; Bae, K. H.; Son, K. H.; Jeong, T. S.; Choi, M. S. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids J. Nutr. 1999, 129, 1182-1185
81. Jeon, S. M.; Park, Y. B.; Choi, M. S. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits Clin. Nutr. 2004, 23, 1025-1034
82. Pu, P.; Gao, D. M.; Mohamed, S.; Chen, J.; Zhang, J.; Zhou, X. Y.; Zhou, N. J.; Xie, J.; Jiang, H. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet Arch. Biochem. Biophys. 2012, 518, 61-70
83. Mulvihill, E. E.; Allister, E. M.; Sutherland, B. G.; Telford, D. E.; Sawyez, C. G.; Edwards, J. Y.; Markle, J. M.; Hegele, R. A.; Huff, M. W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance Diabetes 2009, 58, 2198-2210
84. Sharma, A. K.; Bharti, S.; Ojha, S.; Bhatia, J.; Kumar, N.; Ray, R.; Kumari, S.; Arya, D. S. Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes Br. J. Nutr. 2011, 106, 1713-1723
85. Cho, K. W.; Kim, Y. O.; Andrade, J. E.; Burgess, J. R.; Kim, Y. C. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats Eur. J. Nutr. 2011, 50, 81-88
86. Huong, D. T.; Takahashi, Y.; Ide, T. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids Nutrition 2006, 22, 546-552
87. Jung, U. J.; Lee, M. K.; Park, Y. B.; Kang, M. A.; Choi, M. S. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice Int. J. Biochem. Cell Biol. 2006, 38, 1134-1145
88. Allister, E. M.; Borradaile, N. M.; Edwards, J. Y.; Huff, M. W. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes Diabetes 2005, 54, 1676-1683
89. Allister, E. M.; Mulvihill, E. E.; Barrett, P. H.; Edwards, J. Y.; Carter, L. P.; Huff, M. W. Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor J. Lipid Res. 2008, 49, 2218-2229
90. Borradaile, N. M.; de Dreu, L. E.; Barrett, P. H.; Behrsin, C. D.; Huff, M. W. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation Biochemistry 2003, 42, 1283-1291
91. Borradaile, N. M.; de Dreu, L. E.; Huff, M. W. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation Diabetes 2003, 52, 2554-2561
92. Borradaile, N. M.; Carroll, K. K.; Kurowska, E. M. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin Lipids 1999, 34, 591-598
93. Goldwasser, J.; Cohen, P. Y.; Yang, E.; Balaguer, P.; Yarmush, M. L.; Nahmias, Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARα, PPARγ and LXRα PLoS One 2010, 5, e12399
94. Wilcox, L. J.; Borradaile, N. M.; de Dreu, L. E.; Huff, M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP J. Lipid Res. 2001, 42, 725-734
95. Staels, B.; Dallongeville, J.; Auwerx, J.; Schoonjans, K.; Leitersdorf, E.; Fruchart, J. C. Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 1998, 98, 2088-2093
96. Smith, S. A. Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism Biochem. Soc. Trans. 2002, 30, 1086-1090
97. Lee, M. K.; Bok, S. H.; Jeong, T. S.; Moon, S. S.; Lee, S. E.; Park, Y. B.; Choi, M. S. Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats Bioorg. Med. Chem. 2002, 10, 2239-2244
98. Jeon, S. M.; Bok, S. H.; Jang, M. K.; Kim, Y. H.; Nam, K. T.; Jeong, T. S.; Park, Y. B.; Choi, M. S. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits Clin. Chim. Acta 2002, 317, 181-190
99. Bodet, C.; La, V. D.; Epifano, F.; Grenier, D. Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models J. Periodontal Res. 2008, 43, 400-407
100. Comalada, M.; Ballester, I.; Bailon, E.; Sierra, S.; Xaus, J.; Galvez, J.; de Medina, F. S.; Zarzuelo, A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship Biochem. Pharmacol. 2006, 72, 1010-1021
101. Xagorari, A.; Papapetropoulos, A.; Mauromatis, A.; Economou, M.; Fotsis, T.; Roussos, C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages J. Pharmacol. Exp. Ther. 2001, 296, 181-187
102. Raso, G. M.; Meli, R.; Di Carlo, G.; Pacilio, M.; Di Carlo, R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1 Life Sci. 2001, 68, 921-931
103. Tsai, S. H.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol Br. J. Pharmacol. 1999, 126, 673-680
104. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages Mediators Inflamm. 2007, 2007, 45673
105. Choi, J. S.; Choi, Y. J.; Park, S. H.; Kang, J. S.; Kang, Y. H. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-κ B J. Nutr. 2004, 134, 1013-1019
106. Nizamutdinova, I. T.; Jeong, J. J.; Xu, G. H.; Lee, S. H.; Kang, S. S.; Kim, Y. S.; Chang, K. C.; Kim, H. J. Hesperidin, hesperidin methyl chalone and phellopterin from Poncirus trifoliata (Rutaceae) differentially regulate the expression of adhesion molecules in tumor necrosis factor-α-stimulated human umbilical vein endothelial cells Int. Immunopharmacol. 2008, 8, 670-678
107. Lotito, S. B.; Frei, B. Dietary flavonoids attenuate tumor necrosis factor α-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism J. Biol. Chem. 2006, 281, 37102-37110
108. Lee, E. J.; Kim, D. I.; Kim, W. J.; Moon, S. K. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-α-induced vascular smooth muscle cells Mol. Nutr. Food Res. 2009, 53, 1582-1591
109. Jin, Y. R.; Han, X. H.; Zhang, Y. H.; Lee, J. J.; Lim, Y.; Chung, J. H.; Yun, Y. P. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-γ2 phosphorylation and cyclooxygenase-1 activity Atherosclerosis 2007, 194, 144-152